Simplified Chinese
Tender Notice for the Finished-Product Cold Storage Project of Minhai Biotechnology R&D and Production Building (R&D and Production Building Construction Project)
Release date:
2020-08-07
Author:
Source:
Abstract
I. Project Name: Minhai Biotechnology R&D and Production Building (R&D and Production Building Construction Project) – Finished Goods Cold Storage System
II. Project Overview:
The standard cold storage facility for the Minhai Biotechnology R&D and Production Building (R&D and Production Building Construction Project), invested in and constructed by Beijing Minhai Biotechnology Co., Ltd., is located at No. 35 Simiao Road, Daxing Biomedical Industry Base. This project is primarily intended for the storage of finished vaccine products.
Construction scale: The total floor area of the basement is 380 m². 2 , The room height is 3 meters.
Construction Location: Basement of the R&D and Production Building
Purpose: For storing vaccine products.
Complies with regulatory requirements:
1. Cold Storage Design Code GB 50072-2010;
2. China GMP ( 2010 (Revised in [Year]) and its appendices;
3、 GEP Good Engineering Practice;
III. Scope of the Tender:
The scope of this tender is the general cold storage project for Minhai Bio’s R&D and Production Building (R&D and Production Building Construction Project).
IV. Registration Notes:
1. Participating entities must submit the following documents: the business license of the legal entity, qualification certificates, the safety production license, a certificate of the legal representative or a letter of authorization from the legal representative, and copies of identification documents—four sets in total, with all copies stamped with the official seal of the entity—and must indicate the company’s registered capital.
2. Participating entities must possess the relevant professional qualifications: Grade III qualification for mechanical and electrical installation, GC2 qualification for pressure piping, and demonstrated project experience (with each individual project valued at no less than RMB 3 million).
3. Registration requires the provision of a contact person and contact information from the submitting organization. The contact person must be the project leader or an designated business liaison, and a 12-month social security certificate must be submitted.
4. The tendering entity will review the qualification documents submitted by registered entities, giving priority to those with relevant project experience, and will conduct further communication and on-site inspections with the shortlisted candidates.
5. Beijing Minhai Biotechnology Co., Ltd. was established in 2004 and is a wholly owned subsidiary of Shenzhen Kangtai Biological Products Co., Ltd. (a publicly listed company). For more information, please visit the company’s website.
6. The company’s newly constructed facility includes a finished‑goods warehouse with an area of 3,000 m²; for this tender, the finished‑goods cold storage is designated as the benchmark.
V. Registration Address: Beijing Minhai Biotechnology Co., Ltd. (No. 35, Simiao Road, Bio‑Pharmaceutical Industry Base, Daxing District, Beijing). Contact Persons: Mr. Hao and Ms. Fang, New Project Department; Contact Numbers: 010-57864916, 010-57864911.
Electronic materials have been sent to the email address: wanghao@biominhai.com
VI. Registration Deadline: 5:30 p.m., August 15, 2020.
As the model cold storage facility for the Minhai International Industrial Park project, this undertaking sets a high overall standard. It offers comprehensive functionality, reliable quality, timely completion, stable operation, and convenient maintenance. It is equipped with features such as one‑in‑one‑out redundancy, dual‑circuit power supply, automatic failover, automated control, alarm systems, and a mobile app.
Hereby announced!
Beijing Minhai Biotechnology Co., Ltd.
August 1, 2020
Keywords:
Recommended Reading
Batch Release Status of the Company’s Products in 2026
2026-07-23
2026-07-15
2026-07-09